Cercar

01/01/2022 The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
Querol L.A., Hartung H.-P., Lewis R.A., van Doorn P.A., Hammond T.R., Atassi N., Alonso-Alonso M., Dalakas M.C.. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. Neurotherapeutics. 2022; 19(3)DOI:10.1007/s13311-022-01221-y. PMID:35378684. IF:5.700(Q1/2D).
01/01/2022 Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach
Mayhew A.G., James M.K., Moore U., Sutherland H., Jacobs M., Feng J., Lowes L.P., Alfano L.N., Muni Lofra R., Rufibach L.E., Rose K., Duong T., Bello L., Pedrosa-Hernández I., Holsten S., Sakamoto C., Canal A., Sánchez-Aguilera Práxedes N., Thiele S., Siener C., Vandevelde B., DeWolf B., Maron E., Gordish-Dressman H., Hilsden H., Guglieri M., Hogrel J.-Y., Blamire A.M., Carlier P.G., Spuler S., Day J.W., Jones K.J., Bharucha-Goebel D.X., Salort-Campana E., Pestronk A., Walter M.C., Paradas C., Stojkovic T., Mori-Yoshimura M., Bravver E., Díaz-Manera J., Pegoraro E., Mendell J.R., Straub V.. Assessing the Relationship of Patient Reported Outcome Measures With Functional Status in Dysferlinopathy: A Rasch Analysis Approach. Frontiers in Neurology. 2022; 13DOI:10.3389/fneur.2022.828525. PMID:35359643. IF:3.400(Q2/5D).
01/01/2022 Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score
Doets A.Y., Lingsma H.F., Walgaard C., Islam B., Papri N., Davidson A., Yamagishi Y., Kusunoki S., Dimachkie M.M., Waheed W., Kolb N., Islam Z., Mohammad Q.D., Harbo T., Sindrup S.H., Chavada G., Willison H.J., Casasnovas C., Bateman K., Miller J.A.L., van den Berg B., Verboon C., Roodbol J., Leonhard S.E., Benedetti L., Kuwabara S., van den Bergh P., Monges S., Marfia G.A., Shahrizaila N., Galassi G., Péréon Y., Bürmann J., Kuitwaard K., Kleyweg R.P., Marchesoni C., Sedano Tous M.J., Querol L., Illa I., Wang Y., Nobile-Orazio E., Rinaldi S., Schenone A., Pardo J., Vermeij F.H., Lehmann H.C., Granit V., Cavaletti G., Gutiérrez-Gutiérrez G., Barroso F.A., Visser L.H., Katzberg H.D., Dardiotis E., Attarian S., van der Kooi A.J., Eftimov F., Wirtz P.W., Samijn J.P.A., Jacobus Gilhuis H., Hadden R.D.M., Holt J.K.L., Sheikh K.A., Karafiath S., Vytopil M., Antonini G., Feasby T.E., Faber C.G., Gijsbers C.J., Busby M., Roberts R.C., Silvestri N.J., Fazio R., van Dijk G.W., Garssen M.P.J., Straathof C.S.M., Gorson K.C., Jacobs B.C.. Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score. NEUROLOGY. 2022; 98(5)DOI:10.1212/WNL.0000000000013139. PMID:34937789. IF:9.900(Q1/1D).
01/12/2025 Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis Study
Querol, L, Gómez-Ballesteros, R, Gutierrez-Gutierrez, G, Ares, A, Villaverde, R, Reyes, V, Armangue, T, Salas, E, Diaz-Abós, P, Rebollo, P, Sarmiento, M, Canal, N, Maurino, J, Cortes-Vicente, E. Treatment Preferences of Neurologists in Generalized Myasthenia Gravis: A Conjoint Analysis Study. Neurology and Therapy. 2025; 14(6)DOI:10.1007/s40120-025-00821-y. PMID:40971137. IF:4.800(Q1/2D).
01/11/2025 Adult-onset distal myopathy with predominant hand involvement as a rare phenotype of plectinopathy
Llansó, L, Reyes-Leiva, D, Segarra-Casas, A, Xucla-Ferrarons, T, Gallardo, E, Blanco, R, Gallano, P, Olive, M, Gonzalez-Quereda, L. Adult-onset distal myopathy with predominant hand involvement as a rare phenotype of plectinopathy. Journal Of Neuromuscular Diseases. 2025; 12(6)DOI:10.1177/22143602251350849. PMID:40528517. IF:3.400(Q2/3D).
01/11/2025 Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project
Puig-Ram, C, Segovia, S, Garcia-Uzquiano, R, Garzón, NCÑ, Aragon-Gawinska, K, Romero, MG, Expósito-Escudero, JM, Carrera-García, L, López-Lobato, M, Paradas, C, Mera, LG, Molinero, MA, Andrés, DG, Toro, E, Ramos, JAF, Grimalt, MA, de Laguna, LTB, Barrios, DG, Tizzano, EF, Cattinari, MG, Medina, J, Medina, RC, Munell, F, Sotoca, J, Martínez-Salcedo, E, Escribano, AM, Panadés, MP, Fernández-García, MA, Pitarch-Castellano, I, Vázquez-Costa, JF, Benito, DND, Nascimento, A. Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project. Journal Of Neuromuscular Diseases. 2025; 12(6)DOI:10.1177/22143602251361190. PMID:40726133. IF:3.400(Q2/3D).
01/10/2025 Autoimmune nodopathies: emerging insights and clinical implications
Collet-Vidiella, R, De Lorenzo, A, Querol, L. Autoimmune nodopathies: emerging insights and clinical implications. CURRENT OPINION IN NEUROLOGY. 2025; 38(5)DOI:10.1097/WCO.0000000000001399. PMID:40916889. IF:4.400(Q1/2D).
01/10/2025 From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation
Villalobos, E, Mehra, P, Diaz-Manera, J. From fibro/adipogenic progenitors to adipocytes: Understanding adipogenesis in muscle degeneration for disease modulation. JOURNAL OF PHYSIOLOGY-LONDON. 2025; 603(19)DOI:10.1113/JP288924. PMID:40846464. IF:4.400(Q1/1D).